Active	Status	Sponsor type	Region	Phase	Filter
4 Active 4 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Miller, Timothy E
COURAGE-ALS, NCT04944784 / 2020-004040-29: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)	Terminated	3	489	Europe, Canada, US, RoW	Reldesemtiv, Placebo	Cytokinetics	Amyotrophic Lateral Sclerosis	07/23	07/23
NCT05597436: Intermediate-Sized Expanded Access Study	No Longer Available	N/A		US	Trehalose, SLS-005 Intravenous Trehalose Injection 90.5 mg/mL	Seelos Therapeutics, Inc., Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)	Amyotrophic Lateral Sclerosis
RESTORE, NCT04451525: REal-World Analyses of Stroke - Thrombus Occlusion REtrieval	Recruiting	N/A	1000	US	MicroVention Mechanical Thrombectomy Devices as first-line treatment	Microvention-Terumo, Inc.	Acute Ischemic Stroke, Vessel Occlusion, Stroke, Ischemic	12/25	12/25
WEB PAS, NCT04839705: Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device	Recruiting	N/A	180	US	WEB	Microvention-Terumo, Inc.	Wide Neck Bifurcation Intracranial Aneurysms	12/25	12/29